| Antigen presentation systems for immunotherapeutic vaccines |
| | SLP® | Short Peptides | Recombinant Proteins | Vector delivery
(e.g. viral vector) |
| Presentation | DC processing and presentation | Exogenic MHC binding DC,T,B | DC processing and presentation | DC processing and presentation |
| Induction co-stimulatory signals |  | - |
| |
| Induction imm.resp. subdominant epitopes | | | | - |
| Competition with irrelevant imm. resp. | | | | - |
| Ease of production and purification | | | | |
| Safety | | | | |
| Stability | | | Protein dependent | Vector dependent |
| Costs of goods | | | | |
| Clinical efficacy | | - | | |
